Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Free Cash Flow (2016 - 2026)

Insmed's Free Cash Flow history spans 17 years, with the latest figure at -$226.2 million for Q1 2026.

  • Quarterly Free Cash Flow rose 16.88% to -$226.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$921.6 million through Mar 2026, down 16.77% year-over-year, with the annual reading at -$967.6 million for FY2025, 37.09% down from the prior year.
  • Free Cash Flow came in at -$226.2 million for Q1 2026, up from -$264.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$90.4 million in Q3 2022 to a low of -$272.2 million in Q1 2025.
  • The 5-year median for Free Cash Flow is -$149.7 million (2023), against an average of -$168.2 million.
  • Year-over-year, Free Cash Flow rose 17.46% in 2022 and then tumbled 61.14% in 2025.
  • Insmed's Free Cash Flow stood at -$107.8 million in 2022, then dropped by 23.3% to -$133.0 million in 2023, then tumbled by 52.48% to -$202.8 million in 2024, then tumbled by 30.3% to -$264.2 million in 2025, then increased by 14.37% to -$226.2 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Free Cash Flow are -$226.2 million (Q1 2026), -$264.2 million (Q4 2025), and -$222.2 million (Q3 2025).